| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.14 | 0.009 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.075 | 0.2 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.078 | 0.2 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.069 | 0.2 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.049 | 0.4 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.043 | 0.5 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.035 | 0.5 |